Addressing Challenges to Alternative Payment Models for New Alzheimer's Disease Therapies for US Commercial Payers.

Addressing Challenges to Alternative Payment Models for New Alzheimer's Disease Therapies for US Commercial Payers.
复制标题

解决美国商业付款人新阿尔茨海默病治疗替代支付模式的挑战。

DOI:
10.1007/s40273-022-01150-w
复制
发表时间:
2022-07
期刊:
影响因子:
4.4
通讯作者:
Lin, Pei-Jung
Lin, Pei-Jung
中科院分区:
医学2区
文献类型:
--
作者:
Hlavka, Jakub P.;Lavelle, Tara A.;Neumann, Peter J.;Lin, Pei-Jung

文献摘要

参考文献

相似文献

最终决定覆盖aducanumab或其他阿尔茨海默病疗法的商业支付者可能需要创新的支付工具,以最大限度地降低其财务风险,因为这些治疗的不确定性和高成本。根据已发表的证据,我们提出了两种不同类型的支付模式适用于阿尔茨海默病的疾病修饰疗法,并提出了四种策略,以克服其实施中的挑战。这些策略包括制定阿尔茨海默病结局测量的最佳实践,投资于收集真实世界数据的基础设施,增加阿尔茨海默病登记数据的代表性,以及整合诊断,治疗和支付环境。这些重要步骤可以使阿尔茨海默病的新兴疗法在长期内更具可持续性,并可以作为未来更好地获得其他适应症的新疗法的蓝图。
Commercial payers that ultimately decide to cover aducanumab or other Alzheimer’s disease therapies may require innovative payment tools to minimize their financial risk given the uncertain benefits and high cost of such treatments. Drawing on the published evidence, we propose two different types of payment models applicable to disease-modifying therapies in Alzheimer’s disease, and suggest four strategies to overcome challenges in their implementation. Such strategies range from developing best practices for outcome measurement in Alzheimer’s disease, investing in infrastructure to collect real-world data, increasing representativeness of registry data in Alzheimer’s disease, and integrating the diagnostic, treatment, and payment landscape. These important steps could make access to emerging therapies in Alzheimer’s disease more sustainable in the long term, and could serve as a blueprint for better access to novel therapies in other indications in the future.
DOI: 10.1007/s40273-021-01079-6
发表时间: 2021-09-23
期刊: PHARMACOECONOMICS
影响因子: 4.4
作者:
Mattingly, T. Joseph, II;McQueen, R. Brett;Lin, Pei-Jung
通讯作者: Lin, Pei-Jung
DOI: 10.1002/alz.12433
发表时间: 2022-04
期刊: Alzheimer's & dementia : the journal of the Alzheimer's Association
影响因子: --
作者:
Franzen S;Smith JE;van den Berg E;Rivera Mindt M;van Bruchem-Visser RL;Abner EL;Schneider LS;Prins ND;Babulal GM;Papma JM
通讯作者: Papma JM
DOI: 10.1007/s10198-021-01274-4
发表时间: 2021-06
期刊: The European journal of health economics : HEPAC : health economics in prevention and care
影响因子: --
作者:
Hlávka JP;Yu JC;Goldman DP;Lakdawalla DN
通讯作者: Lakdawalla DN
DOI: 10.1186/s13195-016-0216-8
发表时间: 2016-11-21
期刊: Alzheimer's research & therapy
影响因子: --
作者:
Harrison JK;Noel-Storr AH;Demeyere N;Reynish EL;Quinn TJ
通讯作者: Quinn TJ
DOI: 10.1186/s13195-020-00659-6
发表时间: 2020-07-30
影响因子: 9
作者:
DiBenedetti, Dana B.;Slota, Christina;Hauber, Brett
通讯作者: Hauber, Brett